Literature DB >> 10945983

Molecular characterization of a hyperinducible, surface membrane-anchored, class I nuclease of a trypanosomatid parasite.

M Yamage1, A Debrabant, D M Dwyer.   

Abstract

The 3'-nucleotidase/nuclease (3'-NT/NU) is a surface enzyme unique to trypanosomatid parasites. These organisms lack the pathway for de novo purine biosynthesis and thus are entirely dependent upon their hosts to supply this nutrient for their survival, growth, and multiplication. The 3'-NT/NU is involved in the salvage of preformed purines via the hydrolysis of either 3'-nucleotides or nucleic acids. In Crithidia luciliae, this enzyme is highly inducible. For example, in these organisms purine starvation triggers an approximately 1000-fold up-expression of 3'-NT/NU activity. In the present study, we cloned and characterized a gene encoding this intriguing enzyme from C. luciliae (Cl). Sequence analysis showed that the Cl 3'-NT/NU deduced protein possessed five regions, which we defined here as being characteristic of members of the class I nuclease family. Further, we demonstrated that the Cl 3'-NT/NU-expressed protein possessed both 3'-nucleotidase and nuclease activities. Moreover, we showed that the dramatic up-expression of 3'-NT/NU activity in response to purine starvation of C. luciliae was concomitant with the approximately 100-fold elevation in steady-state mRNA specific for this gene. Finally, results of our nuclear run-on analyses demonstrated that such up-regulation in 3'-NT/NU enzyme activity was mediated at the posttranscriptional level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10945983     DOI: 10.1074/jbc.M004036200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Adaptive responses to purine starvation in Leishmania donovani.

Authors:  Nicola S Carter; Phillip A Yates; Sarah K Gessford; Sean R Galagan; Scott M Landfear; Buddy Ullman
Journal:  Mol Microbiol       Date:  2010-10       Impact factor: 3.501

2.  Episomally driven antisense mRNA abrogates the hyperinducible expression and function of a unique cell surface class I nuclease in the primitive trypanosomatid parasite, Crithidia luciliae.

Authors:  Mat Yamage; Manju B Joshi; Dennis M Dwyer
Journal:  J Mol Biol       Date:  2007-08-21       Impact factor: 5.469

3.  Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania.

Authors:  Matthew B Rogers; James D Hilley; Nicholas J Dickens; Jon Wilkes; Paul A Bates; Daniel P Depledge; David Harris; Yerim Her; Pawel Herzyk; Hideo Imamura; Thomas D Otto; Mandy Sanders; Kathy Seeger; Jean-Claude Dujardin; Matthew Berriman; Deborah F Smith; Christiane Hertz-Fowler; Jeremy C Mottram
Journal:  Genome Res       Date:  2011-10-28       Impact factor: 9.043

4.  Comparative genomics of Tunisian Leishmania major isolates causing human cutaneous leishmaniasis with contrasting clinical severity.

Authors:  Amel Ghouila; Fatma Z Guerfali; Chiraz Atri; Aymen Bali; Hanene Attia; Rabiaa M Sghaier; Ghada Mkannez; Nicholas J Dickens; Dhafer Laouini
Journal:  Infect Genet Evol       Date:  2016-11-04       Impact factor: 3.342

5.  A unique surface membrane anchored purine-salvage enzyme is conserved among a group of primitive eukaryotic human pathogens.

Authors:  A Debrabant; P Bastien; D M Dwyer
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

6.  Characterization of a novel non-specific nuclease from thermophilic bacteriophage GBSV1.

Authors:  Qing Song; Xiaobo Zhang
Journal:  BMC Biotechnol       Date:  2008-04-28       Impact factor: 2.563

Review 7.  Pathogen-Derived Nucleases: An Effective Weapon for Escaping Extracellular Traps.

Authors:  Chengshui Liao; Fuchao Mao; Man Qian; Xiaoli Wang
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

8.  Metabolic reprogramming during purine stress in the protozoan pathogen Leishmania donovani.

Authors:  Jessica L Martin; Phillip A Yates; Radika Soysa; Joshua F Alfaro; Feng Yang; Kristin E Burnum-Johnson; Vladislav A Petyuk; Karl K Weitz; David G Camp; Richard D Smith; Phillip A Wilmarth; Larry L David; Gowthaman Ramasamy; Peter J Myler; Nicola S Carter
Journal:  PLoS Pathog       Date:  2014-02-27       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.